Noticias de MRK_US
Noticias del mercado
Últimas noticias sobre MRK_US — 742 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Merck stock is riding fresh Phase 3 melanoma data for its personalized mRNA therapy intismeran combi
CORDA Investment Management LLC. lessened its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 420,154 shares of the company
Bellars Harris Wealth Management LLC bought a new position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 79,847 shares of the company
Argent Trust Co boosted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 4.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 204,960 shares of the company
ABN AMRO Bank N.V. reduced its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 136,228 shares of the company
Bank of New York Mellon Corp lowered its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,340,173 shares of the company
Meridian Wealth Management LLC increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 79,604 shares of the company
Russell Investments Group Ltd. boosted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,578,024 shares of the company
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 21.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fu
Página 1 de 38